01349nas a2200313   4500000000100000008004100001260001700042653001500059653001000074653001000084653001200094653002000106653003000126653001100156653001100167653001200178653000900190653001300199653002200212100001200234700001200246700001400258245005300272300001000325490000700335050003200342520064700374022001401021       1992                            d  c1992 Apr-Jun10aAdolescent10aAdult10aChild10aDapsone10aDrug Evaluation10aDrug Therapy, Combination10aFemale10aHumans10aleprosy10aMale10aRifampin10aSkin Pigmentation1 aKar P K1 aJha P K1 aSnehi P S00aIndeterminate leprosy: a therapeutic evaluation.  a163-70 v64  aInfolep Library - available3 a<p>Out of 50 cases of indeterminate leprosy, 46 were male and 4 were female. The only clinical finding was a single hypopigmented macule in 38 (76%) cases. Nine (18%) patients had two and three (6%) cases had three hypopigmented macules. All patients were treated with multidrug therapy for one year. At the end of six months, the lesions were still active in 12 (24%) cases. At the end of one year of treatment it was found that 33 (66%) patients became inactive and 3 (6%) cases were still to be active. The study shows that all indeterminate leprosy cases must be treated with multidrug therapy till all signs of activity are subsided.</p>  a0254-9395